| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |